Since apoptosis plays an early role for disease progression and fibrosis development in NAFLD, we asked whether the serological detection of caspase-cleaved keratin-18 fragments (M30) could identify NAFLD patients with fibrotic NASH despite low FIB-4 values (<1.3). This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatotic liver disease.